Revolutionizing Cellular Disease Treatment Through Microtubule-Targeting Drugs
Abstract
Microtubule-targeting drugs have emerged as pivotal therapeutic agents in treating a wide array of cellular diseases. This abstract delves into the revolutionary potential of these drugs in addressing diverse pathological conditions. By elucidating the critical role of microtubules in cellular functions such as cell division, intracellular transport, and structural support, the mechanisms through which microtubule-targeting drugs exert their effects are explored. The abstract further discusses the impact of these drugs on diseases, including cancer, neurodegenerative disorders, and parasitic infections, highlighting their versatility and promising outcomes in clinical settings. Additionally, considerations regarding drug development, challenges, and future directions for optimising their efficacy and minimising adverse effects are contemplated. Ultimately, these abstract underscores the transformative potential of microtubule-targeting drugs in reshaping therapeutic strategies and improving outcomes for various cellular diseases.
How to cite this article:
Kaur J, Sharma A. Revolutionizing Cellular Disease
Treatment Through Microtubule-Targeting Drugs.
J Durg Dis Dev 2024; 8(2): 1-7.
DOI: https://doi.org/10.24321/2581.6861.202401
References
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soer jomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71(3), 209-249.
Wang, C., Li, Y., Liu, Z., Wang, Z., Liu, Z., Man, S., ... & Zhang, W. (2021). Design, synthesis and biological evaluation of 1-aryl-5-(4-arylpiperazine-1-carbonyl)-1 h-tetrazols as novel microtubule destabilizers. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 549-560.
Wieczorek, M., Tcherkezian, J., Bernier, C., Prota, A. E., Chaaban, S., Rolland, Y., ... & Roulston, A. (2016).
The synthetic diazonamide DZ-2384 has distinct effects on microtubule curvature and dynamics without neurotoxicity. Science translational medicine, 8(365), 365ra159-365ra159.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of Drug Discovery and Development ( ISSN:2581-6861)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
